Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Serotec, currently operating as a brand under Bio-Rad Laboratories, is a leading global supplier of antibodies and reagents for life science research. Founded in the United Kingdom in 1982, the company was acquired by MorphoSys in 2006 to form AbD Serotec and was subsequently acquired by Bio-Rad in 2013. The company provides an extensive portfolio of over 10,000 products, including monoclonal and polyclonal antibodies, secondary antibodies, and specialized kits for flow cytometry and immunohistochemistry. Serotec is particularly well-regarded for its comprehensive range of veterinary and immunology-focused reagents, supporting researchers in academic and pharmaceutical sectors worldwide. Their offerings also include custom antibody services and HuCAL technology-derived antibodies for specific research needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Serotec Group.